CHOP Researchers Define Seizure Burden, Developmental Outcomes for STXBP1-Related Disorders
Published on
This major step allows for the creation of clinical trials to test key endpoints that will determine the efficacy of new therapies.
Published on
This major step allows for the creation of clinical trials to test key endpoints that will determine the efficacy of new therapies.
Published on
An experimental compound might be further developed as an effective treatment approach for affected patients.
Published on
Alexis Thompson, MD, MPH, received the award at the society’s annual meeting.
Published on
Shortly after giving birth at Thomas Jefferson University Hospital, Meredith Alley found herself visiting her son, Graham, in the neonatal intensive care unit (NICU). He had arrived earlier than expected and faced respiratory distress that required special care.
Published on
Children’s Hospital of Philadelphia (CHOP) has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma. This three-year gift, named The Connor Initiative: Precision Therapeutics for Osteosarcoma & Rare Cancers, will support cutting-edge research in osteosarcoma and other rare cancers.
Published on
Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders.
Published on
In an abstract presented at AHA, researchers found Black children are more than four times as likely to experience cardiac arrest and have significantly worse survival outcomes.
Published on
Children’s Hospital of Philadelphia (CHOP) announced today that it has earned the 2024 Military Friendly ® Employer designation.
Published on
At this year’s American Academy of Child and Adolescent Psychiatry (AACAP) Conference, Tami Benton, MD, Psychiatrist-in-Chief and Executive Director of the Department of Child and Adolescent Psychiatry and Behavioral Sciences at Children’s Hospital of Philadelphia (CHOP), was welcomed as AACAP’s 36th president for the 2023-2025 term.
Published on
The two studies, presented at ASHG 2023, identified base editing and prime editing approaches for treating the rare newborn genetic disease